絞り込み

16733

広告

Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.

著者 Utianski RL , Botha H , Martin PR , Schwarz CG , Duffy JR , Clark HM , Machulda MM , Butts AM , Lowe VJ , Jack CR , Senjem ML , Spychalla AJ , Whitwell JL , Josephs KA
Brain Lang.2019 Aug 13 ; 197():104676.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

Medical

Other Literature Sources

Many patients who meet core/root criteria for Primary Progressive Aphasia (PPA) are not classifiable as a recognized variant and are often excluded from neuroimaging studies. Here, we detail neurological, neuropsychological, speech and language assessments, and anatomic and molecular neuroimaging (MRI, PiB-PET, and FDG-PET) for fifteen (8 female) clinically unclassifiable PPA patients. Median age of onset was 64 years old with median 3 years disease duration at exam. Three patients were amyloid positive on PiB-PET. 14/15 patients had abnormal FDG-PETs with left predominant hypometabolism, affecting frontal, temporal, parietal, and even occipital lobes. Patients had mild to severe clinical presentations. Visualization of the FDG-PETs principal component analysis revealed patterns of hypometabolism similar to those seen in the PPA variants and suggests the brain regions affected in unclassifiable PPA patients are no different from those who are more easily classifiable. These findings may inform future modifications to the diagnostic criteria to improve diagnostic classification.
PMID: 31419589 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード